Aim: To establish a reverse-phase high performance liquid chromatographic method for the determination of pravastatin in rat liver.
Methods: An aliquot of 5 g liver homogenates, spiked with triamcinolone acetonide (internal standard), was extracted by solid-phase extraction with Bond Elut C18 columns. Chromatography was performed using a C18 reverse-phase column with mobile phase of Na2HPO4 buffer sdution (0.035 mmol.L-1, pH 3.0)-acetonitrile (155:42).
Results: The linear equation was Y = 0.1843X-4.238 x 10(-3) (gamma = 0.9934) in the range of 0.05-10 micrograms.g-1 liver. The limit of detection for pravastatin was 13 ng.mL-1 (signal-to-noise ratio of 3), and the limit of quantification for pravastatin in liver homogenate was 50 ng.g-1 liver (RSD < 20%). The average extraction recovery of pravastatin from liver at different concentrations was 80.8%, and the average inter-day precision was 11%. This procedure was applied to assay pravastatin in rat liver which were collected from Lewis rats at different times after administration of pravastatin (ig 20 mg.kg-1).
Conclusion: The method was sensitive and is feasible for the pharmacokinetic and distribution study of pravastatin.
Download full-text PDF |
Source |
---|
Neurosci Lett
January 2025
Department of Neurology, The University of Arizona, Tucson, AZ 85724, USA; Graduate Interdisciplinary Program in Neuroscience, The University of Arizona, Tucson, AZ 85724, USA; Department of Pharmacology, The University of Arizona, Tucson, AZ 85724, USA. Electronic address:
Sub-anesthetic ketamine has been demonstrated to reduce abnormal involuntary movements (AIMs) in preclinical models of L-DOPA-induced dyskinesia (LID) and retrospective Parkinson's disease (PD) case reports. In this study, we examined the effects on LID of two different statins alone and in combination with ketamine in unilateral 6-hydroxydopamine-lesioned male rats, the standard model for preclinical LID studies. Ketamine attenuated the development of AIMs, while the non-polar lovastatin only showed anti-dyskinetic activity early in the priming period but did not prevent the development of LID, and the polar pravastatin showed no anti-dyskinetic activity.
View Article and Find Full Text PDFSub-anesthetic ketamine has been demonstrated to reduce abnormal involuntary movements (AIMs) in preclinical models of L-DOPA-induced dyskinesia (LID) and retrospective Parkinson's disease case reports. In this study, we examined the effects on L-DOPA-induced dyskinesia of two statins alone and in combination with ketamine in unilateral 6-hydroxydopamine-lesioned male rats, the standard preclinical LID model. Sub-anesthetic ketamine attenuated the development of AIMs, while lovastatin only showed anti-dyskinetic activity at the beginning of the priming but did not prevent the development of LID.
View Article and Find Full Text PDFActa Biomater
December 2024
College of Biological Science and Engineering, Fuzhou University, No. 2 Xueyuan Road, Fuzhou 350108, China; Fujian Key Laboratory of Medical Instrument and Pharmaceutical Technology, Fuzhou University, No. 2 Xueyuan Road, Fuzhou 350108, China. Electronic address:
The healing process of diabetic foot ulcers is challenging due to the presence of a complex and severe inflammatory microenvironment, characterized by hyperglycemia, low pH, susceptibility to infection, vascular dysfunction, and over-expression of reactive oxygen species (ROS), which can potentially lead to amputation or even mortality. Herein, a glucose and pH dual-responsive hydrogel was designed and prepared by crosslinking phenylboronic acid-grafted quaternary chitosan (QF, 4 wt%) with dopamine-grafted oxidized hyaluronic acid (OD, 5 wt%) through phenylboronation, schiff-base reaction, and other techniques. The multifunctional QO/@PV@AB7 hydrogel was prepared by incorporating pravastatin-loaded chitosan nanoparticles (CSNPs@PV, 2 mg/mL) and antimicrobial peptide AMP-AB7 loaded silica nanoparticles (SiONPs@AB7, 0.
View Article and Find Full Text PDFBlood Press
December 2024
Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Naunyn Schmiedebergs Arch Pharmacol
October 2024
Equine and Training Program, Plant and Animal Production Department, Vocational School of Veterinary Medicine, İstanbul University-Cerahpaşa, İstanbul, Turkey.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!